Unlocking Biomarker Discovery with Multiplex Antibody Membrane Arrays đ | Assay Genie Overview of the CRO Service Platforms for Recombinant Protein Expression and Antibody Development Generating protein reagents to evaluate the antibody and CD8+ T cell responses to SARS-CoV-2
A technology for illuminating proteins on the cell surface promises to boost the success of drug discovery, aid in basic research, Off-target binding remains a major challenge in antibody development, often leading to safety concerns and failed programs. Accelerating the Antibody Discovery Workflow in the Modern Therapeutic Landscape
Spotlight on Antibodies is a podcast from â Biointronâ ( , where we bring you the latest antibody Accelerate COVID19 Antibody Discovery With ProSpeed Single B Cell Technology Join us for an exclusive session with Dr. Krishna Bhat, Principal Scientist at IONLACE and former researcher at UmeĂ„ University
Comprehensive Specificity Profiling of Antibody-Based Therapeutics Using the Membrane Proteome Array Originally presented at the Antibody Engineering & Therapeutics Digital Week on June 8-10, 2020. Watch this and the other
Multiple Innovative Technologies & Platforms Empower Antibody Discovery Webinar: AbDropâą Speeds: Accelerating Your Antibody Discovery with Single B Solution Speaker: Gang Liu, Ph.D., Associate
Antibody Discovery | Integral Molecular Rigorous specificity analysis is critical for successful drug development and a safety requirement for monoclonal antibody (mAb) Scientist Stories: Andrew Kruse, GPCRs & Antibody Discovery
Webinar "Next Gen P2X4 Antibody Discovery Enabled by the NativeMP+Phage Display Technology " PEGS Boston Virtual 2020 Presentation: De-Risking Antibody Lead Selection: Is your antibody as specific as you think? by Ben Improving Drug Discovery: A Molecular Understanding of Cell Receptors (Short)
High Throughput Characterization of Ion Channel Activity Blocking mAbs with Array SPR | LSA Platform PRODUCT: Opto Plasma B Discovery 4.0 Product Tour
6 Steps to Success in Discovering Monoclonal Antibodies Against Multipass Membrane Proteins Lessons in Generating Monoclonal Antibodies against Multipass Membrane Proteins- Ross Chambers, PhD
This review discusses various membrane protein nanodiscs, and their applications in antibody discovery, alongside current advancements and challenges. The successful isolation of antibodies from a naive scFv library is described for three membrane bound proteins; human CD83, canine CD117 and bat CD11b.
Targeting Transmembrane Proteins: Facilitating Rapid Advancement in Therapeutic Antibody Discovery Webinar - New Ways to Boost Recombinant Protein and Antibody Yields in Transient Systems Dispensable loops shield the functionally-important extracellular loops of the essential Gram-negative bacterial outer membrane protein LptD
Antibodies Against Membrane Protein Targets | Discovery on Target Antibody Therapies Targeting Complex Membrane Proteins COVID-19 mutant variants | Biology Solutions | High-Throughput Antibody Screening | LSA Platform
Membrane Protein Antibody Discovery, MPS AB5000 | Kyinno Bio Sino Biological is a leading manufacturer of recombinant proteins and antibodies. In addition to our biggest validated recombinant
De-Risking Antibody Lead Selection: Is your antibody as specific as you think? by Ben Doranz, PhD Complex integral membrane proteins, which are embedded in the cell surface lipid bilayer by multiple transmembrane spanning polypeptides, encompass families
Spotlight on Antibodies | Episode 7 | July 1 - 31, 2025 Transient expression is a fast and reliable way to generate recombinant antibodies and proteins (i.e. products) for all research
Latest Developments in High Titer Transient Protein Expression using the ExpiCHO Immunogens with native conformation and a high-throughput IgG cloning platform are two of the most important key components Discovery On Target 2020: Isolation of state-dependent monoclonal antibodies against GLUT4
This is the fourth episode of our DISCOVER MOLECULAR INTERACTIONS webinar series. Each month we will talk about De Novo Design of Epitope-Specific Antibodies for Membrane Proteins with High Specificity & Function Are you working on antibody drug development with a challenging target, such as membrane proteins (e.g. GPCRs and ion
Dr. Mike Taussig, Cambridge Protein Arrays, and Dr. Fridtjof Lund-Johansen, Oslo University Hospital, look at array and Dr Sachdev Sidhu Despite the remarkable growth of antibody-based therapies in recent years, numerous promising targets remain untapped.
Take a tour of our latest antibody discovery workflow, Opto Plasma B Discovery 4.0. DIMA Biotech specializes in expressing and purifying membrane proteins using mammalian cells. Our extensive inventory Discovery of Therapeutic Antibodies Targeting Complex Multi
The human animal is multicellular â an organism comprised of trillions of smaller organisms. As with any complex organisation, Presented By: Natalia Guadalupe Herrera Speaker Biography: My name is Natalia Guadalupe Herrera and I obtained a BS in
Join us live for our webinar, in collaboration with Drug Target Review. Our Chief Technology Officer, Xavier Leroy and Martine Protein Science in Drug Discovery Cracking Protein Structures: From Cryo-EM to Antibody Discovery â A Webinar with Dr. Krishna Bhat
The 13th Annual Antibodies Against Membrane Protein Targets brings together leading researchers and industry innovators to tackle the unique challenges and Looking to streamline your biomarker discovery process? In this video, we dive deep into Assay Genie's Membrane Antibody
Speakers: Andrew Hunt, Phd Student, Northwestern University Alex Pierson, Technical Product Manager for the Access Solutions In this webinar, we introduce single cell technology in immunology and antibody screening, including its emergence, various Massive antibody discovery used to probe structureâfunction
To help Biopharm accelerate its pace on pre-clinical antibody drug lead selection, DIMA Biotech launched an âAll Druggable Isolation of state-dependent monoclonal antibodies against the 12-transmembrane domain SLC2A4 glucose transporter (GLUT4 ) Signal transduction across cell membranes plays a central role in human physiology and disease, yet the mechanistic details
Improve therapeutic monoclonal antibody selection by knowing protein stability using Prometheus Monoclonal antibodies have been an important addition to the biomedical arsenal, but these therapies have limited ability to Complexities of using membrane proteins as antigens in antibody drug discovery, intrinsic challenges & innovative strategies for success.
[GEN Webinars] Towards IND: Specificity Profiling of Antibody-Based Therapies 2025-08-21-DIMA: The Application of Synthetic Nanodisc Technology in Therapeutic Antibody Discovery
Webinar: Conquering Undruggable Targets to Obtain Preclinical Antibodies This presentation, delivered at CAS 2025 and presented by DIMA Biotech, highlights our proprietary platform for the discovery of The discovery and challenges of antibodies targeting GPCRs
MPSA-AB5000 is a high-throughput cell-based platform for identifying the targets of antibodies and other ligands that bind to membrane proteins. Review: Membrane protein nanodiscs for antibody discovery Antibody drug development challenges & solutions
Abstract Transmembrane proteins usually play pivotal roles in various cellular processes, including signal transduction, cell The development of antibody drugs has greatly depended on the establishment of new technologies and platforms, which are
Antibody discovery in weeks versus years - Isolate, culture, and assay tens of thousands of single cells with the Beacon platform Presented by Carterra and Bio-Techne The COVID-19 pandemic and global effort around vaccine development has heightened
Antibody discovery at the edge of impossible Breaking barriers in antibody discovery: harnessing divergent Stabilization of native & functional membrane proteins for drug discovery
PEGS Virtual 2020 Presentation: Integral Molecular has a 95% success rate of discovering high-affinity monoclonal antibodies David MacMillan: A âflashlightâ to identify cellular proteins for drug discovery Presented At: LabRoots - Gibco ExpressionWorld 2017 Presented By: Jon Zmuda, PhD - Director, Cell Biology, Life Sciences
Part 1: Identification of Monoclonal Antibodies that Block Ion Channel Activity Learn how Tetragenetics has developed a strategy Integral Molecular has a 95% success rate of discovering high-affinity monoclonal antibodies against multipass membrane The current review focuses on the ways in which therapeutic antibody discovery and development technologies are evolving the possibilities for antibody-based
Speaker: Dr. Nathan Robertson I Group Leader â Antibody Discovery/Protein Engineering I OXGENE Antibody screening using Webinar: Best Practices for Antibody Specificity Testing for IND Submissions This is the second episode of the second season of the DISCOVER MOLECULAR INTERACTIONS webinar series. Each month
Revolutionizing Drug Development: Synthetic Nanodiscs Visit the Proteomics Analytics Resource Center: In this webinar, Jeffrey Silva, PhD, Principal
Antibody Validation 08: Protein arrays and mass spectrometry Presented At: LabRoots - Gibco ExpressionWorld 2017 Presented By: Anass Jawhari, PhD - Chief Scientific Officer, CALIXAR The MPS Discovery EngineÂź enables the isolation of monoclonal antibodies targeting complex membrane proteins. Click here to learn more.
Using AI and Synthetic Biology to Go Where Antibody Therapies Canât To exploit highly conserved and difficult drug targets, including multipass membrane proteins, monoclonal antibody discovery efforts increasingly rely on the
DISCOVER complex membrane targets: measure binding to GPCRs, ion channels and more directly on cells Webinar: AbDropâą: Accelerating Your Antibody Discovery with Single B Solution | 2025
Targeting Proteomics to Decipher Biology for the Drug Development Pipeline Therapeutic lead antibody discovery and solutions
In this webinar, Dr. Marayna Löwe and Dr. Mathieu Schaff will provide valuable knowledge and practical insights into copolymers TARGATT A Mammalian Cell Library System for Antibody Protein Screening
Webinar: Uni-Selectâą Mammalian Cell-Based Membrane Proteins Antibody Screening Applied StemCell provides Custom Presented By: Dr. Donghui Ma Speaker Biography: Dr. Donghui Ma, an accomplished biotechnology pioneer, serves as the Everyday researchers face the daunting challenge of creating more effective biotherapeutics. Many candidates fail due to a lack of
Presented By: François Romagné Speaker Biography: Professor of immunotechnology at Aix-Marseille University (AMU), Using Single B Technology to Develop Lead Antibody Molecules on GPCR Targets
Protein Science in Drug Discovery Moderators: Vanita D. Sood, EMD Serono & Christopher Koth, Genentech Speakers: Patrick Accelerating Antibody Discovery with Cell Free Protein Synthesis and Automation
Discovery of Potent anti-PD-L1 Antibodies | High-Throughput Antibody Screening | LSA Platform Advancements in AI are revolutionizing antibody design, enabling the creation of epitope-specific antibodies with exceptional
Integrated antibody discovery solution for multi-pass transmembrane target ChemPartner Webinar: Rapid Discovery of a Diverse Panel of Antibodies Against Membrane Targets Targeting membrane proteins for antibody discovery using phage
Therapeutic mAb Discovery for Multi-Pass Transmembrane Protein Targets | DIMA Biotech @ CAS 2025 This webinar assembles experts in antibody discovery and development and features presentations from Integral Molecular,
DISCOVER pure protein-DNA conjugates: preparation, purification, and analysis with the proFIREÂź Discovery Challenges & Strategies - Targeting Membrane Proteins